• Je něco špatně v tomto záznamu ?

GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia

P. Burda, J. Vargova, N. Curik, C. Salek, GL. Papadopoulos, J. Strouboulis, T. Stopka,

. 2016 ; 11 (3) : e0152234. [pub] 20160324

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16027575

Grantová podpora
NV16-27790A MZ0 CEP - Centrální evidence projektů

GATA-1 and PU.1 are two important hematopoietic transcription factors that mutually inhibit each other in progenitor cells to guide entrance into the erythroid or myeloid lineage, respectively. PU.1 controls its own expression during myelopoiesis by binding to the distal URE enhancer, whose deletion leads to acute myeloid leukemia (AML). We herein present evidence that GATA-1 binds to the PU.1 gene and inhibits its expression in human AML-erythroleukemias (EL). Furthermore, GATA-1 together with DNA methyl Transferase I (DNMT1) mediate repression of the PU.1 gene through the URE. Repression of the PU.1 gene involves both DNA methylation at the URE and its histone H3 lysine-K9 methylation and deacetylation as well as the H3K27 methylation at additional DNA elements and the promoter. The GATA-1-mediated inhibition of PU.1 gene transcription in human AML-EL mediated through the URE represents important mechanism that contributes to PU.1 downregulation and leukemogenesis that is sensitive to DNA demethylation therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16027575
003      
CZ-PrNML
005      
20161005132153.0
007      
ta
008      
161005s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0152234 $2 doi
024    7_
$a 10.1371/journal.pone.0152234 $2 doi
035    __
$a (PubMed)27010793
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Burda, Pavel $u Biocev and Pathological Physiology, 1st Faculty of Medicine, Charles University in Prague, Czech Republic. Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
245    10
$a GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia / $c P. Burda, J. Vargova, N. Curik, C. Salek, GL. Papadopoulos, J. Strouboulis, T. Stopka,
520    9_
$a GATA-1 and PU.1 are two important hematopoietic transcription factors that mutually inhibit each other in progenitor cells to guide entrance into the erythroid or myeloid lineage, respectively. PU.1 controls its own expression during myelopoiesis by binding to the distal URE enhancer, whose deletion leads to acute myeloid leukemia (AML). We herein present evidence that GATA-1 binds to the PU.1 gene and inhibits its expression in human AML-erythroleukemias (EL). Furthermore, GATA-1 together with DNA methyl Transferase I (DNMT1) mediate repression of the PU.1 gene through the URE. Repression of the PU.1 gene involves both DNA methylation at the URE and its histone H3 lysine-K9 methylation and deacetylation as well as the H3K27 methylation at additional DNA elements and the promoter. The GATA-1-mediated inhibition of PU.1 gene transcription in human AML-EL mediated through the URE represents important mechanism that contributes to PU.1 downregulation and leukemogenesis that is sensitive to DNA demethylation therapy.
650    _2
$a buněčná diferenciace $x genetika $7 D002454
650    _2
$a DNA-(cytosin-5-)methyltransferasa $x genetika $x metabolismus $7 D004248
650    _2
$a metylace DNA $x genetika $7 D019175
650    _2
$a zesilovače transkripce $7 D004742
650    _2
$a transkripční faktor GATA1 $x genetika $x metabolismus $7 D050982
650    _2
$a regulace genové exprese u leukemie $7 D015973
650    _2
$a histony $x genetika $7 D006657
650    _2
$a lidé $7 D006801
650    _2
$a akutní erytroblastická leukemie $x genetika $x patologie $7 D004915
650    _2
$a akutní myeloidní leukemie $x genetika $x patologie $7 D015470
650    _2
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a vazba proteinů $7 D011485
650    _2
$a protoonkogenní proteiny $x biosyntéza $x genetika $x metabolismus $7 D011518
650    _2
$a trans-aktivátory $x biosyntéza $x genetika $x metabolismus $7 D015534
650    _2
$a genetická transkripce $7 D014158
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vargova, Jarmila $u Biocev and Pathological Physiology, 1st Faculty of Medicine, Charles University in Prague, Czech Republic.
700    1_
$a Curik, Nikola $u Biocev and Pathological Physiology, 1st Faculty of Medicine, Charles University in Prague, Czech Republic. Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
700    1_
$a Salek, Cyril $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
700    1_
$a Papadopoulos, Giorgio Lucio $u Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology-Hellas, Heraklion, Crete, Greece. Department of Biology, University of Crete, Heraklion, Crete, Greece.
700    1_
$a Strouboulis, John $u Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology-Hellas, Heraklion, Crete, Greece.
700    1_
$a Stopka, Tomas $u Biocev and Pathological Physiology, 1st Faculty of Medicine, Charles University in Prague, Czech Republic. 1st Medical Department-Hematology, General Faculty Hospital, Prague, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 11, č. 3 (2016), s. e0152234
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27010793 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20161005132540 $b ABA008
999    __
$a ok $b bmc $g 1165889 $s 952205
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 11 $c 3 $d e0152234 $e 20160324 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
GRA    __
$a NV16-27790A $p MZ0
LZP    __
$a Pubmed-20161005

Najít záznam

Citační ukazatele

Možnosti archivace